speeding ticket "3. Is there any other explanation that the Company may have for the price change and increase in volume in the securities of the Company?
The Company is not aware as to any reason to explain the price change and increase in trading volume in the Company's securities. The Company notes this appeared to follow the Company's announcement on Friday 18th March 2011 providing the market with an update in relation to its compound ATL1101 for prostate cancer. "
ATL1101 Update "Given Professor Gleave's successful studies specifically related to the prostate cancer application of ATL1101, ANP will continue to seek a development partner primarily for this indication. ANP is in discussions with other parties interested in the development of ATL1101 for prostate cancer.
ANP has patent protection for ATL1101 to 2024, extendible up to 2029 in the US, Australia, Europe and Japan. "
ANP Price at posting:
14.0¢ Sentiment: ST Buy Disclosure: Held
